Nisha Padmanabhan

Singapore, 169857, Singapore

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Author Correction: Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation.

Author Correction: Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation.

Journal: Genome biology
Published: June 18, 2021

Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer.

Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer.

Journal: Cancer discovery
Published: May 28, 2021

Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.

Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.

Journal: Genome medicine
Published: March 18, 2021

Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation.

Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation.

Journal: Genome biology
Published: January 28, 2021

Long-read transcriptome sequencing reveals abundant promoter diversity in distinct molecular subtypes of gastric cancer.

Long-read transcriptome sequencing reveals abundant promoter diversity in distinct molecular subtypes of gastric cancer.

Journal: Genome biology
Published: May 31, 2020

DNA epigenetic signature predictive of benefit from neoadjuvant chemotherapy in oesophageal adenocarcinoma: results from the MRC OE02 trial.

DNA epigenetic signature predictive of benefit from neoadjuvant chemotherapy in oesophageal adenocarcinoma: results from the MRC OE02 trial.

Journal: European journal of cancer (Oxford, England : 1990)
Published: July 24, 2019

Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer.

Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer.

Journal: The Journal of clinical investigation
Published: December 10, 2018

Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor.

Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor.

Journal: Scientific reports
Published: February 01, 2018

How to stomach an epigenetic insult: the gastric cancer epigenome.

How to stomach an epigenetic insult: the gastric cancer epigenome.

Journal: Nature reviews. Gastroenterology & hepatology
Published: May 18, 2017

Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.

Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.

Journal: Cancer discovery
Published: April 05, 2017

Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric Adenocarcinoma.

Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric Adenocarcinoma.

Journal: Cancer discovery
Published: September 13, 2016

Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer.

Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer.

Journal: Cellular oncology (Dordrecht, Netherlands)
Published: November 23, 2015
Showing 1-12 of 12

Last Updated: 09/26/2026